John Kirkwood Journalist Profile

Articles

Assessing clonal changes in T cells over time following immunotherapy is a breeze with Cyclone

Sep 9, 2024 | cell.com | John Kirkwood

Get full text accessLog in, subscribe or purchase for full access. References1. Wang, K. ∙ Coutifaris, P. ∙ Brocks, D. ... Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor exhausted CD8+ T cellsCancer Cell. 2017; 42:1582-1597.e102. Wolchok, J.D. ∙ Chiarion-Sileni, V. ∙ Gonzalez, R. ... Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaN. Engl. J. Med. 2017; 377:1345-13563. Tawbi, H.A. ∙ Schadendorf, D. ∙ Lipson, E.J. ...
How Big Tech’s AI Startup Alliances Could Harm Competition

Aug 29, 2024 | promarket.org | John Kirkwood

John B. Kirkwood explains six ways in which Big Tech’s alliances with AI startups could harm competition, making clear that the antitrust agencies have good reason to monitor and investigate them. Editor’s Note: This article is part of a symposium which asks experts to evaluate the anticompetitive harms of Big Tech investments in AI startups in light of recent investigations from antitrust agencies on both sides of the Atlantic.
Dr Kirkwood on the Evolving Treatment of Resected Melanoma

Apr 18, 2024 | onclive.com | John Kirkwood

John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh, discusses the significance of the FDA approval of adjuvant nivolumab (Opdivo) for patients with resected stage IIB or IIC melanoma.
Buttigieg’s New-Look DOT Should Extend Its Winning Streak By Halting the Alaska-Hawaiian Airlines Merger

Dec 21, 2023 | thesling.org | Dylan Gyauch-Lewis |Hal Singer |John Kirkwood

For his first two years as Secretary of Transportation, Pete Buttigieg demurred on critical transportation regulation, especially oversight of airlines. Year three has seen a welcome about-face.
Europe China EV Battle

Oct 18, 2023 | wfmz.com | John Kirkwood

John Kirkwood poses for a selfie with his car near Paston, Norfolk, England, Wednesday, Sept. 27, 2023. Chinese automakers are winning over drivers as they make major inroads into Europe’s electric vehicle market, challenging long-established homegrown brands in an industry that’s key to the continent’s green energy transition. The European Union has launched an investigation into Beijing’s support for its EV industry, adding to tensions between the West and China.
Reforming The Robinson-Patman Act

Jan 24, 2023 | competitionpolicyinternational.com | John Kirkwood

The flaws in the Robinson-Patman Act are well known. It protects competitors at the expense of consumers and rarely stops the buyer-induced discrimination it was meant to prevent. This article proposes reforms that would greatly reduce both problems and explains why adopting those reforms would be preferable to repealing the Act altogether. By John B. Kirkwood[1]I. INTRODUCTIONThe Robinson-Patman Act has two fundamental flaws. First, it is a protectionist statute.